SENS Key Statistics, Chart & Performance
The current stock price of SENS is 7.02 USD. In the past month the price increased by 10.9%. In the past year, price decreased by -21.44%.
SENS Latest News, Press Relases and Analysis
SENS Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.55 | 213.03B | ||
| ISRG | INTUITIVE SURGICAL INC | 64.54 | 197.01B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.41 | 137.38B | ||
| SYK | STRYKER CORP | 26.86 | 135.28B | ||
| IDXX | IDEXX LABORATORIES INC | 55.69 | 56.08B | ||
| BDX | BECTON DICKINSON AND CO | 13.76 | 56.62B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.65 | 48.69B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.4 | 38.48B | ||
| RMD | RESMED INC | 25.4 | 36.70B | ||
| DXCM | DEXCOM INC | 36.33 | 26.35B | ||
| PODD | INSULET CORP | 64.57 | 20.76B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.51 | 18.45B |
Related stock screener links
About SENS
Company Profile
Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
Company Info
SENSEONICS HOLDINGS INC
20451 Seneca Meadows Pkwy
Germantown MARYLAND 20876 US
CEO: Timothy T. Goodnow
Employees: 117
Phone: 13015157260
SENSEONICS HOLDINGS INC / SENS FAQ
Can you describe the business of SENSEONICS HOLDINGS INC?
Senseonics Holdings Inc is a US-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Germantown, Maryland and currently employs 117 full-time employees. The company went IPO on 2015-03-04. Senseonics Holdings, Inc. is a medical technology company focused on the development and manufacturing of glucose monitoring products designed to transform lives in the diabetes community. Its glucose monitoring (CGM) systems Eversense 365 and Eversense E3 include a small sensor inserted completely under the skin that communicates with a smart transmitter worn over the sensor. Its CGM systems are indicated for continually measuring glucose levels for up to 365 days for Eversense 365 and 180 days for Eversense E3 in persons with diabetes age 18 and older. Eversense consists of three primary components: a small sensor inserted subcutaneously under the skin by a healthcare provider; an external removable smart transmitter that receives, assesses and relays data from the sensor and provides vibratory alerts; and a mobile app that receives data from the transmitter and provides real-time glucose readings, alerts and other data the person's mobile device.
What is the current price of SENS stock?
The current stock price of SENS is 7.02 USD.
Does SENSEONICS HOLDINGS INC pay dividends?
SENS does not pay a dividend.
What is the ChartMill rating of SENSEONICS HOLDINGS INC stock?
SENS has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What sector and industry does SENSEONICS HOLDINGS INC belong to?
SENSEONICS HOLDINGS INC (SENS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
When does SENSEONICS HOLDINGS INC (SENS) report earnings?
SENSEONICS HOLDINGS INC (SENS) will report earnings on 2026-03-02, after the market close.
SENS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to SENS. When comparing the yearly performance of all stocks, SENS is a bad performer in the overall market: 86.63% of all stocks are doing better.
SENS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to SENS. SENS scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
SENS Financial Highlights
Over the last trailing twelve months SENS reported a non-GAAP Earnings per Share(EPS) of -1.63. The EPS increased by 37.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -45.39% | ||
| ROE | -72.01% | ||
| Debt/Equity | 0.37 |
SENS Forecast & Estimates
14 analysts have analysed SENS and the average price target is 19.3 USD. This implies a price increase of 174.86% is expected in the next year compared to the current price of 7.02.
For the next year, analysts expect an EPS growth of 36.15% and a revenue growth 59.44% for SENS